Blood-Based Test Predicts Cancer Recurrence & Toxicity from Adjuvant Immunotherapy
Research test developed at Perlmutter Cancer Center pinpoints changes in a newly identified autoantibody panel.
Accelerating Innovations in Early-Phase Oncology Trials
Perlmutter Cancer Center joins national collaborative to address unmet needs through innovative early-phase trials.
Plant-Based Diets: Beneficial for Prostate Cancer?
Systematic review ties plant-based regimen to reduced prostate cancer risk, improved outcomes, and overall health.
Calculator Predicts Risk of Early-Onset Colorectal Cancer
A model incorporating lifestyle, genetic factors could pinpoint high-risk young adults.
Salvage Cryoablation for Radiation-Recurrent Prostate Cancer
Cryoablation is an established therapeutic option for patients with radiation-recurrent prostate cancer.
NYU Langone Health: A Leader in Cancer
cancer hospital in the U.S.
An NCI Comprehensive Cancer Center
active interventional therapeutic clinical trials
Get Practice-Changing Specialty News from the Nation’s #3 Hospital
Select your specialty areas of interest to receive our latest complex case studies, research highlights, expert perspectives, and other news.